Pieter Van Der Veken

22PUBLICATIONS
71CO-AUTHORS
Biologically active moleculesMetabolic medicineMolecular targetsToxicology (incl. clinical toxicology)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 14, 2026
Correction to "Novel Small Molecule-Derived, Highly Selective Substrates for Fibroblast Activation Protein (FAP)".

|Feb 16, 2026
A Novel Fibroblast Activation Protein-Based Algorithm to Assess Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Ziqi V Wang, Badwi B Boumelhem, Torsten Pennell

|Jan 26, 2026
Vectorized ULK1/2 and VPS34 Inhibitors for Tissue-Selective Autophagy Inhibition in Oncology.

Lorenzo Cianni, Kathryn Jacobs, Sergei Grintsevich

|Oct 29, 2025
Selective and Orally Bioavailable Dipeptidyl Peptidase 9 Inhibitors with Potent Pyroptosis Induction Properties.

Nicolò Filippi, Kathleen Mertens, Joni De Loose

|Oct 28, 2025
Fibroblast activation protein promotes natural killer cell invasion and tumor infiltration.

Rachael E Maynard, Allison A Fitzgerald, Emily F Marcisak

|Oct 14, 2025
Structure-Property Investigation of New "KetoFAPI" Inhibitors of Fibroblast Activation Protein (FAP): Discovery of Highly Potent, Selective Compounds with Prolonged Residence Times and Promising Radiotheranostic Potential.

Pawel Brzeminski, Emile Verhulst, Adrian Fabisiak

Pageof 4

Frequent Collaborators

14 joint publications

Koen Augustyns

6 joint publications

Ingrid De Meester

6 joint publications

Hans De Winter

4 joint publications

Filipe Elvas